Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
I-Cure-2: Peginterferon alfa in HBeAg-negative Chronic Hepatitis B
NCT02838810Phase 4Unknown
- Sponsor
- The Third Affiliated Hospital of Sun Yat-sen University
- Start
- Jun 2016
- Primary completion
- Dec 2019
- Countries
- 1
01
Overview
A Phase 4 trial of pegylated interferon alpha in Chronic Hepatitis B (CHB), sponsored by The Third Affiliated Hospital of Sun Yat-sen University. Status: unknown.
02
Drugs
pegylated interferon alpha
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT02838810.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02838810.